The Checkup by Singlecare
APRIL 1, 2025
Olanzapine (brand names Zyprexa or Zyprexa Zydis) is a second-generation antipsychotic medication that’s FDA approved to treat mental health conditions like schizophrenia and bipolar disorder, including mixed or manic episodes. It’s also approved for treatment-resistant depression or depression with bipolar I disorder in combination with fluoxetine.
STAT
APRIL 1, 2025
Layoff notices began arriving early Tuesday for thousands of employees of the sprawling Department of Health and Human Services and its subsidiary agencies, with as many 10,000 workers potentially expected to be hit by the cuts. “I regret to inform you that you have been affected by a reduction in force (RIF) action,” an email to affected employees said.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospital Pharmacy Europe
APRIL 1, 2025
A new toolkit to support pharmacists when integrating artificial intelligence (AI) into daily practice has been launched by the International Pharmaceutical Federation (FIP). The toolkit for hospital, industry and community settings offers structured guidance on AI adoption. It covers ethical considerations, implementation strategies, regulatory compliance and real-world applications to help pharmacists optimise patient care, stimulate multidisciplinary interaction and enhance operational effici
Pharma Marketing Network
APRIL 1, 2025
Introduction How might your pharmaceutical marketing strategy change if your core products suddenly became more expensive to import or export? Pharma tariffs have quickly emerged as a critical consideration for pharma marketing executives, reshaping how brands strategize, position, and market their products globally. As the landscape evolves, marketers need clarity on navigating this complex terrain effectively.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
APRIL 1, 2025
WASHINGTON — Marty Makary’s first official day as commissioner of the Food and Drug Administration began with employees in tears, learning from security guards that they were losing their jobs. The news release announcing the start of his tenure points readers to a press office that, after large-scale layoffs, basically no longer exists.
The FDA Law Blog
APRIL 1, 2025
By Dr. Naomi Lowy, Principal Drug Regulatory Expert Trade and national press have reported that recent changes in FDA staffing levels have already led to slower responses to calls and emails. According to reports, which were published before the most recent reports of HHS staff level reductions and tumultuous changes in leadership, FDA staff were missing minor deadlines.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
OctariusRx
APRIL 1, 2025
OctariusRx President and Consultant Pharmacist Victor Alves is presenting Pharmacy Documentation: Tips for Patient Safety and Survey Success at the ASCA 2025 Conference & Expo, April 30May 3, in Denver Colorado. He will discuss the essential elements of patient safety through complete pharmacy documentation. Additionally, he will address the most common survey issues and provide practical tips for improving patient safety and survey success.
STAT
APRIL 1, 2025
A coalition of state attorneys general sued the Trump administration on Tuesday over its decision to cut $11 billion in federal funds that go toward Covid-19 initiatives and various public health projects across the country. Attorneys general from 23 states filed the suit in federal court in Rhode Island. They include New York Attorney General Letitia James, Colorado Attorney General Phil Weiser, Kentucky Gov.
European Pharmaceutical Review
APRIL 1, 2025
Researchers have demonstrated a novel framework that supports the advancement of quality control in manufacturing. Current quality control strategies are often inefficient for large process uncertainties, as they often do not provide the flexibility necessary, due to a reliance on set-point control, Kay et al. explained. This therefore raises a clear need for more advanced and robust optimal control strategies to maintain product quality.
STAT
APRIL 1, 2025
The CDC cuts announced Tuesday threaten America’s health, safety, and economy. Despite claims of efficiency, these cuts target proven programs that prevent disease and save lives — and as a result, Americans will be sicker and face increased health care costs. The government’s goal should not be to hit an arbitrary number of jobs eliminated, but to focus on the number of illnesses and premature deaths prevented.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmafile
APRIL 1, 2025
Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide) significantly reduced the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes and cardiovascular disease (CVD) and/or chronic kidney disease (CKD). The new phase 3b data was presented at the American College of Cardiologys (ACC) Annual Scientific Session […] The post Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial appeared
STAT
APRIL 1, 2025
In 2024, total U.S. spending on prescription drugs was almost $800 billion. Although low-cost generic drugs filled 91% of all prescriptions, the 9% of prescriptions filled with a branded medicine accounted for 84% of drug spending. The monopolies on new drugs last so long, launch prices are so high, and price increases are so steep that they more than wipe out the savings Congress hoped to achieve by encouraging robust generic competition.
Pharmafile
APRIL 1, 2025
Corcept Therapeutics announced that relacorilant plus nab-paclitaxel met its primary endpoint of improved progression-free survival in ROSELLA, the companys phase 3 trial of the therapy. The ROSELLA trial enrolled 381 patients with platinum-resistant ovarian cancer across sites internationally. Patients were randomised 1:1 to receive either relacorilant plus nab-paclitaxel or nab-paclitaxel alone.
STAT
APRIL 1, 2025
NEW YORK — U.S. Attorney General Pam Bondi said Tuesday she has directed federal prosecutors to seek the death penalty against Luigi Mangione, the man accused of gunning down UnitedHealthcare CEO Brian Thompson outside a New York City hotel on Dec. 4. Mangione, 26, faces separate federal and state murder charges for the killing, which rattled the business community while also galvanizing health insurance critics.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmafile
APRIL 1, 2025
Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) taking place 25 to 30 April 2025 in Chicago, Illinois, US. Data will showcase SECN-15s potential to significantly improve the efficacy of immune checkpoint inhibitors (ICIs). Secarna is a biopharma company which develops and redefines […] The post Secarna Pharmaceuticals to announce positive new data at cancer research conference appeared first on
STAT
APRIL 1, 2025
Workers across the Centers for Disease Control and Prevention were summarily fired on Tuesday, triggering what will be an unprecedented and chaotic withdrawal of the agency from many areas of disease prevention on which it has long worked. In all, the CDC is expected to lose roughly 2,400 employees, or about 18% of its staff, as part of the broader cuts playing out across the Department of Health and Human Services.
Drug Topics
APRIL 1, 2025
Community pharmacies have a clear role in public health, as they manage ongoing services and take on a more significant role as immunizers.
STAT
APRIL 1, 2025
The tariffs being proposed by the Trump administration on pharmaceuticals may cause shortages and raise prices for numerous medicines that are made in Canada and sold in the U.S., a new analysis suggested. An estimated $3 billion in pharmaceuticals sold in the U.S. each year are produced, at least in part, in Canadian manufacturing facilities, and if President Trump proceeds with reported plans to impose 25% tariffs, this would lead to another $750 million in costs for Americans, according to th
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
APRIL 1, 2025
Researchers explored the efficacy of a targeted mailing campaign for improving pneumococcal vaccination coverage among adults 65 and over.
STAT
APRIL 1, 2025
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. In March, an office at the federal health department announced it would not enforce requirements that electronic health records have fields to record and exchange patients’ sexual orientation and gender identity.
Drug Topics
APRIL 1, 2025
The outpatient endoscopic procedure modifies duodenal dysfunction and restores metabolic health.
STAT
APRIL 1, 2025
This story originally appeared in STAT’s sister publication, The Boston Globe. The deepening Trump administration budget cuts have hit Mass General Brigham, the nation’s largest hospital recipient of research grants, and other Massachusetts universities and hospitals, canceling tens of millions in funding and shutting down medical research programs in areas such as primary care, reproductive health, and pandemic preparedness.
Drug Topics
APRIL 1, 2025
In this episode of the podcast, Shawn and Jesse outline 3 key principles about teamwork that can drive success in the pharmacy.
Pharmacy Times
APRIL 1, 2025
Current recommended levels of vitamin B12 might not be sufficient to protect against neurological decline.
Drug Topics
APRIL 1, 2025
The approval expands the flexibility of storing the vaccine to protect against smallpox events or mpox outbreaks.
PharmaVoice
APRIL 1, 2025
The lack of clear communication from the government could spark wide-ranging issues in pharma — from sowing confusion about clinical trial design to further eroding public trust.
Drug Topics
APRIL 1, 2025
Jenny Markell, BA, joined us to discuss the nuances of drug promotion in the US and how specific medications are targeted to various patient populations.
PharmaVoice
APRIL 1, 2025
Dr. Mikael Dolsten, Pfizer’s former chief scientific officer, is embarking on a journey of curiosity and interconnectedness in his post-Big Pharma career.
Drug Topics
APRIL 1, 2025
In an era of persistent medical misinformation, addressing vaccine hesitancy has become a critical challenge for health care professionals.
Pharmacy Times
APRIL 1, 2025
The CDC reports 483 total cases across 20 states as of March 28, 2025.
pharmaphorum
APRIL 1, 2025
Reduction in force (RIF) job losses have started in earnest at US federal agencies, including the FDA and CDC, according to media reports
Pharmacy Times
APRIL 1, 2025
Given rituximabs tendency to cause infections in patients being treated for autoimmune diseases, the addition of intravenous immunoglobulin works to reduce that risk and induce clinical improvements.
pharmaphorum
APRIL 1, 2025
EVERSANA has joined the growing roster of companies partnering with Veeva on the development of GenAI applications for the life sciences industry
Expert insights. Personalized for you.
Let's personalize your content